Abstract
Utilization of patient-reported outcome measures (PROMs) to guide symptom management during radiation therapy has shown to be more sensitive to changes in health status and might detect the exact onset of the toxic effects of radiotherapy more accurately than clinician-reported outcomes. The Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) is a validated 16-item, diseasespecific PROM that targets the unique needs of men with prostate cancer (PCa) and evaluates the five HRQOL domains of urinary incontinence, urinary irritation/obstruction, bowel related symptoms, sexual dysfunction and hormonal symptoms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
